Large Cap Biotech
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
Trend Stats
Today's % Change
-1.39%
1-Month Return
+1.31%
3-Month Return
+22.14%
12-Month Return
+41.28%
Volatility Score
2.1
ST Trend
Neutral
LT Trend
Up
Short-Term Trend
Neutral
The Short-Term Trend is a metric that gauges an ETF's short-term price trend.
Long-Term Trend
Up
The Long-Term Trend is a metric that gauges an ETF's long-term price trend.
Performance
Large Cap Biotech
S&P 500 Index
Components
| Symbol | Company | Market Cap | % change Today's percentage change | 1 mo return Performance over the past month | 12 mo return Performance over the past 12 months | Vol Score Our gauge of the ETF's recent volatility | ST Trend A metric that gauges an ETF's short-term price trend | LT Trend A metric that gauges an ETF's long-term price trend |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen | $207B | -2.25% | -7.79% | +39.03% | 2.8 | Down | Up |
| GILD | Gilead Sciences | $180B | -0.58% | +8.83% | +26.07% | 2.4 | Up | Up |
| VRTX | Vertex Pharma | $130B | -1.26% | -1.78% | +29.49% | 2.5 | Neutral | Up |
| REGN | Regeneron Pharma | $82B | -1.78% | -1.72% | +40.33% | 2.5 | Up | Up |
| ARGX | arGEN-X SpADR | $62B | -1.82% | +13.62% | +28.88% | 3.4 | Up | Up |
| MRNA | MODERNA | $55B | +0.74% | +128.42% | +438.09% | 12.4 | Up | Up |
| NTRA | Natera | $47B | -1.26% | +2.45% | +87.64% | 3.2 | Up | Up |
| RVMD | REVOLUTION MEDIC | $44B | -2.08% | -1.75% | +339.77% | 3.9 | Neutral | Up |
| ONC | BeOne Medi Sp ADR | $39B | -2.62% | -4.79% | +1.83% | 2.7 | Neutral | Up |
| ALNY | Alnylam Pharma | $33B | -4.07% | +14.07% | -47.18% | 4.2 | Down | Down |
| BIIB | Biogen | $32B | +2.23% | +4.01% | +44.74% | 2.7 | Neutral | Up |
| ILMN | Illumina | $30B | -1.82% | +4.94% | +102.67% | 4.5 | Neutral | Up |
| ROIV | ROIVANT SCIENCES | $30B | -2.08% | +14.42% | +184.11% | 3.7 | Up | Up |
| INSM | Insmed | $28B | -1.18% | -5.54% | -12.69% | 3.6 | Up | Down |
| INCY | Incyte | $25B | -2.17% | +1.42% | +43.07% | 2.7 | Neutral | Up |
| BNTX | BioNTech Sp ADR | $24B | -1.76% | +3.88% | -7.58% | 5.0 | Down | Down |
| UTHR | United Therapeut | $22B | -0.58% | -4.87% | +24.46% | 2.8 | Down | Down |
| GMAB | GENMAB SP ADR | $20B | -2.45% | +4.41% | +12.65% | 2.5 | Up | Up |
| ASND | Ascendis Pharma Br | $17B | +0.16% | +2.19% | +32.15% | 3.2 | Neutral | Up |
| MEDP | Medpace Holdings | $16B | -0.54% | -3.20% | +17.20% | 2.8 | Neutral | Up |
| NBIX | Neurocrine Biosc | $16B | +0.92% | -5.06% | +9.03% | 2.7 | Down | Up |
| EXEL | Exelixis | $14B | -1.54% | +8.44% | +46.99% | 2.5 | Up | Up |
| BBIO | BRIDGEBIO PHARMA | $14B | -4.71% | -14.37% | +37.83% | 3.4 | Down | Down |
| SMMT | SUMMIT THERAP | $14B | -3.08% | +14.32% | -8.60% | 5.8 | Up | Up |
| CRL | Charles Riv Lab | $13B | -1.92% | -1.44% | +70.90% | 3.3 | Up | Up |
| BMRN | Biomarin Pharm | $13B | +1.71% | -4.89% | +17.17% | 2.7 | Up | Up |
| MDGL | Madrigal Pharmct | $12B | -2.48% | +3.45% | +21.32% | 3.6 | Neutral | Up |
| HALO | Halozyme Therape | $12B | -0.36% | +4.27% | +38.01% | 2.5 | Up | Up |
| ARWR | Arrowhead Phrmct | $12B | +0.16% | -6.31% | +178.47% | 3.8 | Down | Up |
| TECH | Bio-Techne | $11B | -0.24% | +0.06% | +36.23% | 0.3 | Neutral | Up |
| AXSM | Axsome Therapeut | $11B | +0.23% | -4.43% | +71.69% | 3.0 | Down | Up |
| TEM | TEMPUS AI-A | $11B | -4.14% | +6.68% | -33.84% | 8.1 | Up | Up |
| CYTK | Cytokinetics | $10B | -0.66% | -4.99% | +38.07% | 3.4 | Down | Up |
| KRYS | KRYSTAL BIOTECH | $10B | -0.73% | +4.21% | +139.37% | 3.2 | Down | Up |
| ABVX | ABIVAX SP ADS | $10B | -2.94% | -9.06% | +34.89% | 3.5 | Down | Down |
| KYMR | KYMERA THERAP | $9.7B | +1.36% | +7.75% | +153.25% | 4.5 | Neutral | Up |
| PRAX | PRAXIS PRECIS | $9.5B | -1.95% | -7.74% | +758.88% | 5.1 | Down | Up |
| PTGX | Protagonist Ther | $9.4B | +0.05% | -3.23% | +143.23% | 3.9 | Neutral | Up |
| RGEN | Repligen | $9.3B | -0.22% | +0.93% | +37.80% | 4.3 | Up | Up |
| IONS | Ionis Pharmaceut | $9.2B | -0.66% | -2.27% | -13.10% | 3.7 | Down | Down |
| 0 | 0 | 0 | 0 | Bullish | Bullish |